These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32761562)
1. Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity. Yang K; Wei M; Yang Z; Fu Z; Xu R; Cheng C; Chen X; Chen S; Dammer E; Le W Cell Oncol (Dordr); 2020 Dec; 43(6):1175-1190. PubMed ID: 32761562 [TBL] [Abstract][Full Text] [Related]
2. ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression. Yang K; Luan L; Li X; Sun X; Yin J J Neurooncol; 2022 Jan; 156(1):123-137. PubMed ID: 34797524 [TBL] [Abstract][Full Text] [Related]
3. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking. Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066 [TBL] [Abstract][Full Text] [Related]
4. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy. Xu JX; Yang Y; Zhang X; Luan XP Anat Rec (Hoboken); 2021 Feb; 304(2):342-352. PubMed ID: 32275350 [TBL] [Abstract][Full Text] [Related]
5. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor D1 agonist inhibits glioblastoma via calpain‑mediated ER stress and mitochondrial dysfunction. Yang K; Xu R; Le W Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760205 [TBL] [Abstract][Full Text] [Related]
7. The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions. Xue Z; Zhang Y; Zhao R; Liu X; Grützmann K; Klink B; Zhang X; Wang S; Zhao W; Sun Y; Han M; Wang X; Hu Y; Liu X; Yang N; Qiu C; Li W; Huang B; Li X; Bjerkvig R; Wang J; Zhou W J Exp Clin Cancer Res; 2024 Jan; 43(1):25. PubMed ID: 38246990 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057 [TBL] [Abstract][Full Text] [Related]
10. Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells. Zhu Z; Zhang P; Li N; Kiang KMY; Cheng SY; Wong VK; Leung GK Biomed Res Int; 2019; 2019():2710693. PubMed ID: 31662972 [TBL] [Abstract][Full Text] [Related]
11. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway. Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes. Shojaei S; Koleini N; Samiei E; Aghaei M; Cole LK; Alizadeh J; Islam MI; Vosoughi AR; Albokashy M; Butterfield Y; Marzban H; Xu F; Thliveris J; Kardami E; Hatch GM; Eftekharpour E; Akbari M; Hombach-Klonisch S; Klonisch T; Ghavami S FEBS J; 2020 Mar; 287(5):1005-1034. PubMed ID: 31545550 [TBL] [Abstract][Full Text] [Related]
13. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway. Cheng Y; Xie P J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386 [TBL] [Abstract][Full Text] [Related]
14. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732 [TBL] [Abstract][Full Text] [Related]
15. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate. Ou M; Cho HY; Fu J; Thein TZ; Wang W; Swenson SD; Minea RO; Stathopoulos A; Schönthal AH; Hofman FM; Tang L; Chen TC Autophagy; 2023 Dec; 19(12):3169-3188. PubMed ID: 37545052 [TBL] [Abstract][Full Text] [Related]
17. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway. Yuan Y; Xue X; Guo RB; Sun XL; Hu G CNS Neurosci Ther; 2012 Jul; 18(7):536-46. PubMed ID: 22530672 [TBL] [Abstract][Full Text] [Related]
19. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma. Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606 [TBL] [Abstract][Full Text] [Related]
20. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. Johannessen TC; Hasan-Olive MM; Zhu H; Denisova O; Grudic A; Latif MA; Saed H; Varughese JK; Røsland GV; Yang N; Sundstrøm T; Nordal A; Tronstad KJ; Wang J; Lund-Johansen M; Simonsen A; Janji B; Westermarck J; Bjerkvig R; Prestegarden L Int J Cancer; 2019 Apr; 144(7):1735-1745. PubMed ID: 30289977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]